Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.
about
Roles of microRNAs in atherosclerosis and restenosisAngiogenesis in old-aged subjects after ischemic stroke: a cautionary note for investigatorsFeatures of atherosclerosis in the tunica adventitia of coronary and carotid arteries in a black kenyan population.Vasa vasorum anti-angiogenesis through H₂O₂, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain.HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.Adipokines and the cardiovascular system: mechanisms mediating health and disease.Naturally derived factors and their role in the promotion of angiogenesis for the healing of chronic wounds.Thrombosis formation on atherosclerotic lesions and plaque rupture.Potential contributions of intimal and plaque hypoxia to atherosclerosis.Potential therapeutic effects of mTOR inhibition in atherosclerosis.Provisional matrix: A role for versican and hyaluronan.IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation.Screening of antiangiogenic potential of twenty two marine invertebrate extracts of phylum Mollusca from South East Coast of India.Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease.Gene expression profiling of articular cartilage reveals functional pathways and networks of candidate genes for osteochondrosis in pigs.Modifications of microvascular EC surface modulate phototoxicity of a porphycene anti-ICAM-1 immunoconjugate; therapeutic implications.The multitasking role of macrophages in Stanford type A acute aortic dissection.The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo.Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor.Association between carotid plaque enhancement shown by multidetector CT angiography and histologically validated microvessel density.
P2860
Q27012949-73A0416A-2708-4C1C-B58E-7A00B1D55128Q34397776-8CF60E68-DAA7-4CEC-B87C-157704F605CAQ35159213-101933AE-6463-4A4E-BEBA-0E8970795014Q35238044-2871D004-2F93-4892-A840-9DEA8C3EFE2CQ36221840-89E97BDF-9106-48D5-9A7E-330B16082140Q36429790-F49DB344-EFE8-48C1-B96F-F743005ED8B7Q37281446-B8F1A7EF-3365-4E26-A863-4D5970546F8AQ37696318-BDDED0D7-473E-4FF7-8A29-FE39D8BC4366Q38014474-D994F731-BA7A-453E-A4CF-964308B6A8D9Q38082427-B60C5BC2-BAA8-401C-9DDD-24A1DC68C295Q38243253-2402A3CE-CAF2-4259-B094-6DE671A0EB71Q38422308-3D11BBCA-CFE0-4FA1-BDF2-2F00B2825DC3Q38628797-C6D681FE-25D8-4256-A79D-640F5617B4D8Q39033619-8F564C34-94E4-4DBC-97F1-6B16AC87334AQ39496836-6BB32005-A0DB-4952-A634-661946BB2231Q39721891-C84EA4F9-0647-414D-8580-0920263B9BE4Q42581726-E350F305-4799-4E99-BD9D-A3E5E1CDE68AQ42612741-880F7DD5-DC23-4C36-B097-F5A856DC323CQ42831090-3254305C-9608-480C-A07F-C4A309C665D5Q44622914-EB6B1AA8-A63A-4BAE-A5E6-C6A93BD53294Q44945907-5724CD90-9D36-4DBE-94B5-823755628E8CQ51557632-8E4EDDD9-FE1B-4A28-A78E-9DA7D0961D00Q53162357-08669F23-B0DD-4D11-81B6-4C2A6EB68D8F
P2860
Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Controlling the angiogenic swi ...... for therapeutic intervention.
@en
Controlling the angiogenic swi ...... for therapeutic intervention.
@nl
type
label
Controlling the angiogenic swi ...... for therapeutic intervention.
@en
Controlling the angiogenic swi ...... for therapeutic intervention.
@nl
prefLabel
Controlling the angiogenic swi ...... for therapeutic intervention.
@en
Controlling the angiogenic swi ...... for therapeutic intervention.
@nl
P2860
P356
P1476
Controlling the angiogenic swi ...... for therapeutic intervention.
@en
P2093
Jerzy Krupinski
Mark Slevin
P2860
P2888
P356
10.1186/2040-2384-1-4
P50
P577
2009-09-21T00:00:00Z
P5875
P6179
1053593121